Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas”
1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10975142
Endotrophin neutralization and use thereof
granted -
US 10966950
Use of an RXR agonist in treating HER2+ cancers
granted -
US 10967065
Compounds for treating biofilm infection
granted -
US 10960029
Devices and methods for umbilical cord processing
granted -
US 10959952
Use of exosomes for the treatment of disease
granted -
US 10953110
Dual emissive metal nanoparticles as ratiometric pH indicators
granted -
US 10953031
Compounds and methods for treating neurological and cardiovascular conditions
granted -
US 10953209
Treating tumors using TTFields combined with a PARP inhibitor
granted -
US 10954217
Sigma receptor binders
granted -
US 10946096
Nitrobenzaldehyde proton release for manipulation of cellular acidosis
granted -
US 10947206
cGAS antagonist compounds
granted -
US 10933078
Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling
granted -
US 10925977
Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
granted -
US 10925928
Method for treating chemotherapy-induced male infertility
granted -
US 10918657
Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
granted -
US 10918732
Glycoconjugates and methods for their use
granted -
US 10912791
Compositions comprising antisense-encoded erythropoietin receptor and use thereof
granted -
US 10907158
Antisense antibacterial compounds and methods
granted -
US 10899740
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
granted -
US 10897891
Compositions and methods for prolonged cell storage
granted -
US 10898451
Methods of treating anti-NMDA receptor encephalitis with tramadol
granted -
US 10898437
Formation of stable submicron peptide or protein particles by thin film freezing
granted -
US 10894044
Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of cancer
granted -
US 10894052
Heterocyclic inhibitors of ATR kinase
granted